Cargando…
Long-term reduction in the incidence of aplastic anemia and immune thrombocytopenia during the COVID-19 pandemic
Autores principales: | Sakurai, Masatoshi, Kogure, Yasunori, Mizuno, Kota, Matsuki, Eri, Kataoka, Keisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483361/ https://www.ncbi.nlm.nih.gov/pubmed/36794506 http://dx.doi.org/10.3324/haematol.2022.282351 |
Ejemplares similares
-
Association of Severe Thrombocytopenia and Poor Prognosis in Pregnancies with Aplastic Anemia
por: Shin, Jae Eun, et al.
Publicado: (2014) -
Cephalosporin-induced recurrent aplastic anemia
por: Han, Jimin, et al.
Publicado: (2010) -
Aplastic anemia, membranous nephropathy and mercury
por: Rooney, J.
Publicado: (2013) -
Management of aplastic anemia during the phase of defervescence of the COVID-19 pandemic()
por: Vallejo Llamas, Juan Carlos
Publicado: (2021) -
SARS-CoV-2 infection in aplastic anemia
por: Avenoso, Daniele, et al.
Publicado: (2021)